# Perioperative Stress Hyperglycemia in General and Vascular Surgery Patients

> **NCT04862234** · PHASE4 · TERMINATED · sponsor: **Emory University** · enrollment: 16 (actual)

## Conditions studied

- Hyperglycemia Stress

## Interventions

- **DRUG:** Dulaglutide
- **DRUG:** Placebo
- **DEVICE:** Continuous glucose monitor (CGM), blinded

## Key facts

- **NCT ID:** NCT04862234
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-08-06
- **Primary completion:** 2023-06-22
- **Final completion:** 2023-06-22
- **Target enrollment:** 16 (ACTUAL)
- **Why stopped:** This clinical trial was terminated on June 7, 2024 due to new information about contraindications of using the study drug in this population.
- **Last updated:** 2025-01-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04862234

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04862234, "Perioperative Stress Hyperglycemia in General and Vascular Surgery Patients". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04862234. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*